Effects of fetal antiepileptic drug exposure: Outcomes at age 4.5 years

Neurology

Volumn 78, Issue 16, 2012, Pages 1207-1214

  Meador, K J ^a   Baker, G A ^b   Browning, N ^c   Cohen, M J ^d   Bromley, R L ^e   Clayton Smith, J ^f   Kalayjian, L A ^g   Kanner, A ^h   Liporace, J D ⁱ   Pennell, P B ^j   Privitera, M ^k   Loring, D W ^a  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c EMMES CORPORATION   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f ST MARY S HOSPITAL   (United Kingdom)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h RUSH UNIVERSITY MEDICAL CENTER   (United States)

ⁱ Neurology   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k UNIVERSITY OF CINCINNATI   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; CHILD; COGNITION; COGNITIVE DEFECT; DRUG EFFECT; FEMALE; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; VERBAL BEHAVIOR;

EID: 84860744226     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318250d824     Document Type: Article

References (40)

1. Fisher JE, Vorhees CV. Developmental toxicity of antiepileptic drugs: Relationship to postnatal dysfunction. Pharmacol Res 1992;26:207-221.
2. Gaily E, Meador KJ. Neurodevelopmental effects. In: Engel J, Pedley TA, eds. Epilepsy: A Comprehensive Textbook, 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2007:1225-1233.
3. Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360:1597-1605.
4. FDA Drug Safety Communication: Children born to mothers who took Valproate products while pregnant may have impaired cognitive development (6/30/2011). Available at: Http://www.fda.gov/Drugs/DrugSafety/ucm261543.htm. Accessed March 1, 2012.
5. Kluger BM, Meador KJ. Teratogenicity of antiepileptic medications. Semin Neurol 2008;28:328-335.
6. Harden CL, Meador KJ, Pennell PB, et al. Practice Parameter update: Management issues for women with epilepsy: Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:133-141.
7. Sattler JM. Assessment of Children, 3rd ed. San Diego: Jerome M. Sattler; 1992.
8. Hollingshead AB. Four Factor Index of Social Status. New Haven, CT: Yale University; 1975.
9. Elliott CD. Differential Abilities Scales, 2nd ed. San Antonio, TX: The Psychological Corporation; 1990.
10. Bayley N. Bayley Scales of Infant Development, 2nd ed. San Antonio, TX: The Psychological Corporation; 1993.
11. Brown L, Sherbenou RJ, Johnsen SK. Test of Non-verbal Intelligence (TONI-3), 3rd ed. Austin, TX: Pro-Ed; 1996.
12. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI). San Antonio, TX: Psychological Corporation; 1999.
13. Nelson H, Willison J. National Adult Reading Test (NART). Oxford, UK: NFER-Nelson Publishing; 1991.
14. Li KH. Imputation using Markov chains. J Stat Comput Simul 1988;30:57-79.
15. Little RJA, Rubin DB. Statistical Analysis with Missing Data, 2nd ed. New York: John Wiley & Sons, Inc.; 2002.
16. Rosenbaum P, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
17. Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-1583. (Pubitemid 39430610)
18. Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004;62:28-32. (Pubitemid 38082865)
19. Thomas SV, Ajaykumar B, Sindhu K, Nair MK, George A, Sarma PS. Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav 2008;13:229-236.
20. Bromley RL, Mawer G, Love J, et al, Liverpool and Manchester Neurodevelopment Group [LMNDG]. Early cognitive development in children born to women with epilepsy: A prospective report. Epilepsia 2010;51:2058-2065.
21. Shallcross R, Bromley RL, Irwin B, Bonnett LJ, Morrow J, Baker GA, Liverpool Manchester Neurodevelopment Group, UK Epilepsy and Pregnancy Register. Child development following in utero exposure: Levetiracetam vs sodium valproate. Neurology 2011;76:383-389.
22. Nadebaum C, Anderson V, Vajda F, Reutens D, Barton S, Wood A. The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy. J Int Neuropsychol Soc 2011;17:133-142.
23. Meador KJ, Baker GA, Browning N, et al. NEAD Study Group. Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain 2011; 134:396-404.
24. Sawrie SM, Chelune GJ, Naugle RI, Luders HO. Empirical methods for assessing meaningful neuropsychological change following epilepsy surgery. JINS 1996;2:556-564. (Pubitemid 126449822)
25. Hermann BP, Seidenberg M, Schoenfeld J, Peterson J, Leveroni C, Wyler AR. Empirical techniques for determining the reliability, magnitude, and pattern of neuropsychological change after epilepsy surgery. Epilepsia 1996;37:942-950. (Pubitemid 26314954)
26. Thomas SV, Sukumaran S, Lukose N, George A, Sarma PS. Intellectual and language functions in children of mothers with epilepsy. Epilepsia 2007;48:2234-2240. (Pubitemid 350243416)
27. Ikonomidou C, Bittigau P, Ishimaru MJ, et al. Ethanolinduced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000;287:1056-1060. (Pubitemid 30094364)
28. Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002;99:15089-15094. (Pubitemid 35334614)
29. Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann NY Acad Sci 2003;993:103-114. (Pubitemid 36808438)
30. Glier C, Dzietko M, Bittigau P, Jarosz B, Korobowicz E, Ikonomidou C. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 2004;187: 403-409. (Pubitemid 38610286)
31. Manthey D, Asimiadou S, Stefovska V, et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 2005;193:497-503. (Pubitemid 40616197)
32. Katz I, Kim J, Gale K, Kondratyev A. Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther 2007;322:494-500. (Pubitemid 47105802)
33. Kim JS, Kondratyev A, Tomita Y, Gale K. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 2007;48(suppl 5):19-26. (Pubitemid 47512198)
34. Medina AE, Krahe TE, Coppola DM, Ramoa AS. Neonatal alcohol exposure induces long-lasting impairment of visual cortical plasticity in ferrets. J Neurosci 2003;23: 10002-10012. (Pubitemid 37392546)
35. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: An unblinded randomised controlled trial. Lancet 2007;369: 1016-1026. (Pubitemid 46436125)
36. Kondratyev A, Gale K, Tsukerman S. Phenobarbitalinduced apoptosis in the neonatal rat brain occurs in a limited compartment of neurons: American Epilepsy Society 2010. abstract 2.156. Available at: Http://www.aesnet. org/go/publications/aes-abstracts/abstract-search/mode/ display/st/gale/sy/2010/ sb/All/id/12750. Accessed March 1, 2012.
37. Harden CL, Hopp J, Ting TY, et al. Practice Parameter update: Management issues for women with epilepsy: Focus on pregnancy (an evidence-based review): Obstetrical complications and change in seizure frequency: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:126-132.
38. Harden CL, Pennell PB, Koppel BS, et al. Practice Parameter update: Management issues for women with epilepsy: Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:142-149.
39. Tomson T, Battino D, Bonizzoni E, et al, for the EURAP study group. Dose-dependent risk of malformations with antiepileptic drugs: An analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10: 609-617.
40. Pennell PB, Hovinga CA. Antiepileptic drug therapy in pregnancy I: Gestation-induced effects on AED pharmacokinetics. Int Rev Neurobiol 2008;83:227-240.